The two are not the same, and they are different from each other, and their anti-inflammatory effects are not the same, so it is not appropriate to compare which one has a better anti-inflammatory effect in a general sense.

1, Erythromycin: Mainly effective against Gram-positive bacteria and some mycoplasmas and chlamydiae, it can penetrate the bacterial cell membrane, block the binding of ribosomes, thereby inhibiting the synthesis of bacterial proteins and achieving antibacterial effects. Diseases such as purulent streptococcal infection, mycoplasma pneumonia, chlamydia pneumonia, and neonatal conjunctivitis caused by chlamydia trachomatis, as well as reproductive system infections, can all be used in clinical practice;

2, Cephalosporins: Mainly act by inhibiting bacterial transpeptidase, interfering with the synthesis of bacterial cell walls, killing bacteria during the reproductive period, and is an effective antibacterial agent. Since human cells do not have cell walls, it has a strong effect on bacteria and is basically harmless to humans. After several years of development, there are already 5 varieties of cephalosporins, with a large number of drugs. Ceftriaxone is a commonly used third-generation drug, mainly used for treating respiratory system infections caused by Streptococcus pneumoniae, with broad-spectrum and good antibacterial effects. It has strong antibacterial activity against both Gram-positive, Gram-negative, and anaerobic bacteria and can be used for various infections caused by sensitive bacteria.